Drug profile · INN
recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from trichoplusia ni cell)
CERVARIX
- Patents linked
- 0
- News articles
- 0
Quick answer
recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from trichoplusia ni cell) (CERVARIX) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from trichoplusia ni cell)
Brand CERVARIX
Frequently asked questions
What is recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from trichoplusia ni cell)?
recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from trichoplusia ni cell) (CERVARIX) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from trichoplusia ni cell)?
CERVARIX is a marketed brand name for recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from trichoplusia ni cell). Check FDA Drugs@FDA for the current US label holder and prescribing information.